Global Computational Biology Market Size By End-User (Industry, Commercial, Academics), By Application (Preclinical Drug Development, Human Body Simulation Software), By Geographic Scope And Forecast

Computational Biology Market Size And Forecast

Computational Biology Market size was valued at USD 4,861.41 Million in 2021 and is projected to reach USD 26,313.85 Million by 2030, growing at a CAGR of 20.64% from 2023 to 2030.

The increasing penetration of research studies as a result of drug development and discovery is the primary factor driving market growth. The Global Computational Biology Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Computational Biology Market Definition

Imagine biology as a puzzle, with cells, genes, and proteins as the pieces. Computational systems biology is like a computer game that lets us simulate how these pieces interact within cells and between different cells. Thanks to advances in genetics, protein studies, and chemical analysis, we now have tons of data to help us create these simulations. We use different methods, like equations, diagrams, and computer models, to show how cells behave over time and in different places. This has been a game-changer in drug discovery. By understanding how drugs interact with cells, we can design more effective treatments and speed up the development process. Computational systems biology has become a powerful tool for biologists, giving them a virtual playground to explore the complexities of life.

With advances in computing and programming, computer scientists have become valuable allies in the quest to understand diseases. They use a powerful tool called computational modeling, which combines math, physics, and computer programming to create virtual copies of complex systems, like the human body. These models are packed with information about different aspects of a system, and scientists can experiment with them by changing these factors individually or together. By observing the changes in the model, they can gain insights into how real systems behave. Computer scientists have harnessed this technique to help track infectious diseases in communities, identify the most effective ways to contain outbreaks, and monitor and adjust measures to prevent the spread of disease.

When a nasty bug strikes, it's a race against time to figure out how to stop it and ease the strain on our hospitals. That's where computers come to the rescue. They crunch mountains of health data, spotting patterns and offering up personalized advice for each patient. These computer whizzes help doctors make the right calls, from picking the best hospital room to ordering the right tests. And they're also helping scientists whip up new medicines that are safe and as gentle on patients as possible, speeding up the process of getting them to people who need them.

Global Computational Biology Market Overview

Computational biology has a wide range of applications in genomics, proteomics, pharmacogenomics, and drug development. Because these services must maintain computational biology sets in order to carry out various drug development processes, many companies turn to third-party services for drug discovery and clinical trials. The pharmaceutical industry’s emphasis on speeding up development and improving accuracy in drug development will lead to greater adoption of computational biology.

The expansion of the Computational Biology Market may be hampered by a severe shortage of trained professionals. According to (NIEHS), the lack of a link between human data and experimental data (animal and mechanistic) makes understanding these findings difficult. The human data is of the “correct” species, is linked to “real-life” exposures, and demonstrates a level of consistency that is difficult to dismiss. In terms of demonstrating a cause-and-effect link, epidemiological studies have significant limitations, whereas laboratory research is designed to do so.

Almost all laboratory findings in animals and humans, as well as the majority of mechanistic research in cells, contradict a causal relationship between ELF-EMF exposure at low levels in the environment and changes in biological function or disease status. The molecular activities are not perfect, and DNA computing contains significant errors. As the problem’s complexity increases, the likelihood of receiving an incorrect response eventually outnumbers the likelihood of receiving a correct answer.

Global Computational Biology MarketSegmentation Analysis

The Global Computational Biology Market is segmented on the basis of End-User, Application, And Geography.

Computational Biology Market, By End-User

• Industry
• Commercial
• Academics

Based on End-User, The market is classified into Industry, Commercial, and Academics. Biology and biomedical research are being revolutionized by exciting breakthroughs in biotechnology. High-throughput sequencing, high-throughput quantitative PCR, intracellular imaging, in-situ gene expression hybridization, and three-dimensional imaging techniques such as Light Sheet Fluorescence Microscopy and Optical Projection (micro)-Computer Tomography are examples of these approaches.

Given the vast amounts of complex data created by these systems, effective interpretation and even storage pose significant obstacles that necessitate novel ways. Computational science and engineering (CSE) is a relatively new discipline concerned with the development and application of computational models and simulations, often in conjunction with high-performance computing, to solve complex physical problems arising in engineering analysis and design (computational engineering) and natural phenomena (computational science).

Computational Biology Market, By Application

• Preclinical Drug Development
• Human Body Simulation Software
• Drug Discovery & Disease Modelling
• Cellular & Biological Simulation
• Others

Understanding the Human Body Simulations Market The market for human body simulations is divided into different categories based on how they're used. These categories includePreclinical Drug DevelopmentThis is the process of testing new drugs in the lab before they're tested on humans. These tests help identify the best drug candidate, develop the best way to make the drug, choose the best dosage and how often to take it, and design clinical trials. Human Body Simulation Software These are computer programs that can mimic the human body or specific parts of it. They're used to study diseases and how they affect the body, as well as to test new drugs and treatments. Drug Discovery & Disease ModellingThese simulations are used to find new drugs and treatments for diseases. They can also be used to study how diseases develop and spread. Cellular & Biological Simulation These simulations focus on studying cells and how they work together. They're used to understand diseases at a cellular level and to develop new treatments. OthersThis category includes other types of human body simulations that don't fit into the other categories.Preclinical Drug DevelopmentWhat It InvolvesPreclinical drug development is a complex process that involves several steps Identifying the best drug candidate from a group of options Developing the best method for scaling up drug production Determining the best way to give the drug to patients, including the dose, how often it's given, and how long the treatment lasts Designing the clinical trial to test the drug on humans Each preclinical development process is unique, but they all share some common features. For example, they all use animal models to study the drug's effects and safety. Animal models can help researchers identify the drug's pharmacokinetic profile (how the body absorbs, distributes, and eliminates the drug) and overall safety, as well as detect any potential toxicity.

Computational Biology Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

If we look at different regions around the world, North America, Europe, Asia Pacific, and the rest of the world are the main markets for computational biology. In the coming years, Asia Pacific is expected to grow the fastest. This is mainly because computational biology has so many different uses. Many companies use third-party services for drug discovery and clinical trials because these services need to keep computational biology data in order to run different drug development processes. The pharmaceutical industry's focus on making drug development faster and more accurate will lead to more use of computational biology.

Key Players

The “Global Computational Biology Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Accelrys, Chemical Computing Group Inc., Entelos, In-silico Biotechnology AG, Nimbus Discovery LLC, Rhenovia Pharma SAS, Certara, Compugen Ltd, Generate AG, Leadscope Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• May 2021. Certara, Inc., the world leader in biosimulation, has released new versions of its Quantitative Systems Pharmacology (QSP) Simulators for Immunogenicity (IG) and Immuno-oncology (IO) to aid in the development of biologics and cancer treatments.
• March 2021, Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, has published a review article titled “Therapeutic Targeting of Checkpoint Receptors within the DNAM-1 Axis,” which looks at the biology and therapeutic relevance of the DNAM-1 axis in cancer immunotherapy.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

Human-Friendly Version Unlocking Market Insights Our report digs deep into the market, exploring both its economic and non-economic aspects. We've broken it down into segments, so you can easily see the value of each part. Tracking Growth Trends We've identified the regions and segments that are poised to grow the fastest. So, you can stay ahead of the curve and make informed decisions. Regional Analysis We've analyzed how the product or service is being used in different regions. Plus, we've pinpointed the factors driving market growth in each area. Competitive Advantage Get the inside scoop on the major players in the market, including their rankings, new offerings, partnerships, and acquisitions. Company Profiles Dive into the details of each major company, from their mission to their products and strengths. Market Outlook We'll give you a clear picture of where the industry is headed, considering both the opportunities and challenges it faces. Industry Analysis We'll use Porter's Five Forces analysis to give you a comprehensive look at the market's dynamics. Value Chain Insights Follow the flow of the product or service through the market, uncovering key value drivers. Future Prospects We'll guide you through the growth opportunities that lie ahead, helping you stay ahead of the competition. Ongoing Support Our analysts will be available to assist you for six months after you purchase the report, ensuring you have everything you need to make the most of your investment.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.